RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer
RX-5902 是一种新型 β-catenin 调节剂,可增强免疫检查点抑制剂在三阴性乳腺癌临床前模型中的疗效。
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-020-07500-1
Tentler, John J; Lang, Julie; Capasso, Anna; Kim, Deog Joong; Benaim, Ely; Lee, Young B; Eisen, Andrew; Bagby, Stacey M; Hartman, Sarah J; Yacob, Betelehem W; Gittleman, Brian; Pitts, Todd M; Pelanda, Roberta; Eckhardt, S Gail; Diamond, Jennifer R